Sienna Biopharma Seeks To Convert Its Ch. 11 Case
By Vince Sullivan ( December 16, 2019, 5:25 PM EST) -- Dermatology treatment developer Sienna Biopharmaceuticals Inc. asked a Delaware bankruptcy judge late Friday to convert its Chapter 11 case to a Chapter 7 liquidation as it no longer had its lenders' consent to use their cash collateral and was unsuccessful in selling some of its assets at auction....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.